Actavis, Inc. (ACT)
|
87.45
+0.32 (+0.37%)
|
|
|
|
ACT additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACT Profile
•
Exchange
NYSE
•
Held by these Mutual Funds
Not Available
•
Executives
Mr. Paul M. Bisaro
Chief Exec. Officer
Pres and Director
Mr. R. Todd Joyce
Chief Financial Officer -Global
Mr. David A. Buchen
Chief Legal Officer -Global
Mr. George Frederick Wilkinson
Pres of Global Brands and Biosimilars
Mr. Sigurdur Oli Olafsson
Pres of Global Generics
Chief Exec. Officer
Pres and Director
Mr. R. Todd Joyce
Chief Financial Officer -Global
Mr. David A. Buchen
Chief Legal Officer -Global
Mr. George Frederick Wilkinson
Pres of Global Brands and Biosimilars
Mr. Sigurdur Oli Olafsson
Pres of Global Generics
•
Index Membership
N/A
•
Employee Count
6,686
Special Offers
Competitors
ACT earnings
Date
Actual
Expected
Prev Yr Qtr
7/1/2008
1.35
1.28
1.09





